The tumor infiltrating lymphocyte panel described here allows for quantification of general lymphocyte populations, such as B cells, NK cells, CD4 T cells and CD8 T cells, and a minimal classification of differentiation status of T cells, including memory, effector or naïve phenotypes and regulatory T cells. The gene discussed is CD8A; the disease is neoplasm.